by Shari Basch | Oct 14, 2024 | Company, Management Team
Anand Sundaram brings more than a decade of commercial experience in brand strategy, marketing, access and reimbursement, digital, and sales across retina, cardiovascular, and infectious disease to Opthea. Mr. Sundaram joins the company from Astellas (formerly Iveric...
by Shari Basch | Oct 8, 2024 | Company, Management Team
Mr. Bitter brings broad experience in strategic planning and corporate development for life sciences companies, including two completed M&A transactions. Most recently, he led business development at Graybug Vision to in‐license several development programs for...
by Shari Basch | Oct 8, 2024 | Company, Management Team
Anthony Bonifazio brings more then 25 years of commercial experience in market access, advocacy, reimbursement, and sales across retina, cardiovascular and oncology. Mr. Bonifazio joins Opthea from Astellas (former IVERIC BIO) where he served as Vice President,...
by Shari Basch | Oct 8, 2024 | Company, Management Team
Dr. Han’s career in biotechnology and pharmaceutical industry spans over 25 years, with 19 years in ophthalmology. He brings experience in early and late‐stage drug development in both anterior and posterior ophthalmology. He has a proven track record of success in...
by Samuel Nee | Oct 8, 2024 | Company, Management Team
Mr. O’Neill has over 30 years of experience in the manufacturing of biopharmaceuticals including 20 years with Amgen where he gained extensive experience in all aspects of lifecycle management including quality, engineering, production, development, supply chain and...
by Samuel Nee | Oct 8, 2024 | Company, Management Team
Ms. Adams is directly accountable to the board, through the chair, on all matters to do with the proper functioning of Opthea’s board. Prior to joining Opthea, Ms. Adams was the Chief Financial Officer of the Victor Smorgon Group in Melbourne. Ms. Adams has over...
